Stephen T. Abedon - Concepedia

Author

Stephen T. Abedon

The Ohio State University at Mansfield ORCID

Also Known As

Abedon, Stephen T., S T Abedon, S. T. Abedon, S.T. Abedon, STEPHEN T. ABEDON, Stephen Abedon, Stephen T Abedon, Stephen T. Abedon, Stephen Tobias Abedon

180

Publications

13.2K

Citations

H-Index

Concepts

All Affiliations

The Ohio State University at Mansfield The Ohio State University University of Arizona

About

Stephen T. Abedon is an author at The Ohio State University at Mansfield specializing in medicine, microbiology, and biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	31	4.6K
2	Engineering	3	3	388
3	Health Sciences	3	3	242
4	Natural Sciences	1	1	31
5	Public Health	1	1	79

Stephen T. Abedon

Publications

Citations

H-Index

Page 1

	Year	Citations
Pros and cons of phage therapy Catherine Loc-Carrillo, Stephen T. Abedon Bacteriophage Phage PotentialBacteriophagePharmacotherapyMicrobial VirusTreatment Resistance	2011	979
Phage treatment of human infections Stephen T. Abedon, Sarah J. Kuhl, Bob Blasdel, Bacteriophage Phage UseProbioticPhage TreatmentBacteriophagePhage Safety	2011	949
Lysogeny in nature: mechanisms, impact and ecology of temperate phages Cristina Howard‐Varona, Katherine R. Hargreaves, Stephen T. Abedon, The ISME Journal	2017	832
Lysis from without Stephen T. Abedon Bacteriophage BiologyPhage EclipsePathogenesisBacteriologyBacteriophage	2011	389
Practical Methods for Determining Phage Growth Parameters Paul Hyman, Stephen T. Abedon Methods in molecular biology	2009	307
Bacteriophage Latent-Period Evolution as a Response to Resource Availability Stephen T. Abedon, Troy D. Herschler, David Stopar Applied and Environmental Microbiology BiologyAbstract BacteriophagesEngineeringMedicinePhage Biology	2001	278
Phage Therapy Pharmacology Benjamin K. Chan, Stephen T. Abedon Advances in applied microbiology Translational MedicinePharmacologyPharmacotherapyMedicineTreatment Development	2012	211
Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth Stephen T. Abedon, Katarzyna Danis‐Wlodarczyk, Daniel J. Wozniak Pharmaceuticals Activity BreadthBacteriophageMicrobial VirusDrug ResistancePhage Therapy	2021	195
Experimental Examination of BacteriophageLatent-Period Evolution as a Response to BacterialAvailability Stephen T. Abedon, Paul Hyman, Cameron Thomas Applied and Environmental Microbiology	2003	187
Phage therapy dosing: The problem(s) with multiplicity of infection (MOI) Stephen T. Abedon Bacteriophage	2016	170

Page 1